Company Filing History:
3 out of 80 
2 out of 122 
1 out of 1 Years Active: 2004-2018
Title: Andrew Mark Lew - Innovator in Dendritic Cell Research
Introduction
Andrew Mark Lew is an accomplished inventor based in Essendon, Australia, with a notable portfolio of 8 patents. His innovative work primarily focuses on the identification and utilization of dendritic cell markers, which hold significant potential for advancements in immunology.
Latest Patents
One of Andrew Mark Lew’s latest patents is centered around the identification of proteins located on the surface of dendritic cells and their precursors. This invention particularly addresses antigen-presenting dendritic cells. It involves the development of compounds, such as antibodies, that bind to these proteins. These compounds can serve multiple purposes, including detecting and enriching specific subsets of dendritic cells or their precursors. Furthermore, they can be strategically used to target antigens to dendritic cells, thereby modulating humoral and T cell-mediated immune responses, or to target cytotoxic agents to dendritic cells involved in disease states.
Career Highlights
Andrew has had an impactful career working with leading research institutions. He has been affiliated with the Walter and Eliza Hall Institute of Medical Research and CSL Limited, which underscores his commitment to advancing medical science through research and innovation.
Collaborations
Throughout his career, Andrew has collaborated with esteemed professionals, including Brent Steven McKenzie and Jefferey Stephen Boyle. These collaborations have played a critical role in the development of his inventions and the enhancement of research outcomes in their field.
Conclusion
Andrew Mark Lew stands out as a pioneering inventor dedicated to the field of immunology, particularly through his innovative work on dendritic cell markers. His contributions not only reflect significant advancements in research but also highlight the importance of collaboration in the scientific community. As an inventor, Lew continues to play a vital role in shaping the future of immunological research and therapy.